Motus GI Holdings with ticker code (MOTS) have now 6 analysts covering the stock. The analyst consensus points to a rating of ‘Strong_Buy’. The target price ranges between 3 and 2 with the average target price sitting at 2.5. Given that the stocks previous close was at 0.97 this is indicating there is a potential upside of 157.7%. There is a 50 day moving average of 0.9 and the 200 day moving average is 1.05. The company has a market capitalisation of $32m. Visit the company website at: http://www.motusgi.com
Motus GI Holdings, a medical technology company, provides endoscopy solutions that enhance clinical outcomes and the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions in the United States and Israel. Its flagship product is the Pure-Vu system, a medical device to facilitate the cleaning of a poorly prepared colon during the colonoscopy procedure. The company is based in Fort Lauderdale, Florida.